Ionis and Roche reported positive Phase 3 data for a kidney drug.
No further details were immediately available.


Ionis and Roche said their Phase 3 trial for a kidney treatment yielded positive data.

Ionis and Roche reported positive Phase 3 data for a kidney drug.
No further details were immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Más de Priya Anand →

